Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure

JAMA: The Journal of the American Medical Association

Volumn 273, Issue 18, 1995, Pages 1450-1456

  Garg, Rekha ^a   Yusuf, Salim ^a  

^a Collaborative Group on ACE Inhibitor Trials ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENAZEPRIL; CAPTOPRIL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL MALEATE; LISINOPRIL; PERINDOPRIL; QUINAPRIL; RAMIPRIL;

ADULT; AGED; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DOSE RESPONSE; FEMALE; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAUSE OF DEATH; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGE; MORBIDITY; RANDOMIZED CONTROLLED TRIALS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 0028955321     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1995.03520420066040     Document Type: Article

References (56)

1. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
2. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med. 1987;316:1429-1435.
3. Yusuf S, Peto R, Lewis J, Sleight P. Beta-blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;17:335-371.
4. Early Breast Cancer Trialists' Collaborative Group. Effect of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. N Engl J Med. 1988;319:1681-1692.
5. Held PH, Teo KK, Yusuf S. Effects of beta-blockade, calcium channel blockers, and nitrates in acute myocardial infarction and unstable angina pectoris. In: Topol EJ, ed. Textbook of Interventional Cardiology. Philadelphia, Pa: WB Saunders Co; 1991:49-65.
6. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
7. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-748.
8. Colfer HT, Ribner HS, Gradman A, Hughes V, Kapoor A, Laideau JC, for the Benazepril Heart Failure Study Group. Effects of once-daily benazepril therapy on exercise tolerance and manifestations of chronic congestive heart failure. Am J Cardiol. 1992;70:354-358.
9. McGarry R. Randomized, Double Blind, Multicenter Study Comparing Benazepril to Digoxin and to Placebo as Add On Therapy to Diuretic in Patients With CHF, NYHA Class II-III During a 12-Week Treatment Period, GHBA-194. Summit, NJ: Ciba-Geigy Pharmaceuticals; September 1991. Unpublished report.
10. Magnani B, Magelli C, for the Multicenter Research Groups on Mild Heart Failure. Captopril in mild heart failure: preliminary observations of a long-term double-blind, placebo-controlled multi centre trial. Postgrad Med J. 1986;62(suppl I):153-158.
11. Bussmann WD, Storger H, Hadler D, et al. Long-term treatment of severe chronic heart failure with captopril: a double-blind randomized, placebo-controlled long-term study. J Cardiovasc Pharmacol. 1987;9(suppl 2):S50-S60.
12. Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA. 1988;259:539-544.
13. Newman TJ, Maskin CS, Dennick LG, Meyer JH, Hallows BG, Cooper WH. Effects of captopril on survival in patients with heart failure. Am J Med. 1988;84(suppl 3A):140-144.
14. Barabino A, Galbariggi G, Pizzorni C, Lotti G. Comparative effects of long-term therapy with captopril and ibopamine in chronic congestive heart failure in old patients. Cardiology. 1991;78:289-296.
15. Kleber FX, Niemoller L, Doering W. Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich mild heart failure trial. Br Heart J. 1992;67:289-296.
16. Niitani H, Hisakazu Y, Kawai C, et al. Clinical study of captopril (CS-522 CHF) on chronic heart failure: multicenter double blind study in comparison with placebo [in Japanese]. Rinshioyaku. 1992; 8:1273-1291.
17. Magnani B, Rizzon R. SCIC—Sopravivenza con Captopril nell' Insufficienza Cardiaca: Protocol. Bologna, Italy: SCIC—Sopravivenza con Captopril nell' Insufficienza Cardiaca; 1990.
18. Drexler H, Banhardt BS, Meinertz T, Wollschlager H, Lehmann M, Just H. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure: a double blind, placebo controlled trial. Circulation. 1989;79:491-502.
19. Cleland JGF, Dargie HJ, Ball SG, et al. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J. 1985;54: 305-311.
20. Rucinska EJ. A Double Blind Placebo Controlled Study to Evaluate the Effects of Enalapril in Patients With Chronic Heart Failure. West Point, Pa: Merck Sharpe & Dohme Research Laboratories; September 1991. Unpublished report.
21. Enalapril CHF Investigators. Long-term effects of enalapril in patients with congestive heart failure: a multicenter, placebo-controlled trial. Heart Failure. 1987;3:102-107.
22. Dickstein K, Barvik S, Aarsland T. Effect of long-term enalapril therapy on cardiopulmonary exercise performance in men with mild heart failure and previous myocardial infarction. J Am Coll Cardiol. 1991;18:596-602.
23. Rucinska EJ. Enalapril vs Placebo in Previously Untreated Patients With CHF. West Point, Pa: Merck Sharpe & Dohme Research Laboratories; September 1991. Unpublished report.
24. Zwehl W, Rucinska E, for Lisinopril Chronic Heart Failure Investigators. Long-term effects of lisinopril in patients with chronic heart failure: a multicenter, placebo-controlled trial. In: Nicholls MG, ed. A Focus on the Clinical Effects of a Long Acting ACE-Inhibitors/Heart Failure. New York, NY: Raven Press; 1990:31-40.
25. Giles TD, for Lisinopril Chronic Heart Failure Group. Lisinopril treatment of congestive heart failure-results of a placebo controlled trial. Circulation. 1990;82(suppl 4):III-323. Abstract.
26. Rucinska EJ. Lisinopril First-Line Therapy in CHF. West Point, Pa: Merck Sharpe & Dohme Research Laboratories; September 1991. Unpublished report.
27. Gilbert EM, Sandoval A, Larabee P, Renlund D, O'Connell JB, Bristow MR. Lisinopril lowers cardiac adrenergic drive and increases β-receptor density in the failing human heart. Circulation. 1993;88:472-480.
28. Lechat P, Garnham J, Desche P, Bounhoure JP. Efficacy and acceptability of perindopril in mild to moderate chronic congestive heart failure. Am Heart J. 1993;126:798-826.
29. Riegger GAJ. The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure. J Cardiovasc Pharmacol. 1990;15 (suppl 2):41-46.
30. Northridge DB, Rose E, Elder A, et al. A multicenter, double-blind, placebo-controlled trial of quinapril in mild chronic heart failure. Eur Heart J. 1991;12(suppl):184. Abstract.
31. Uprichard A.A 16-Week Double Blind, Placebo-Randomized Placebo Controlled Multicenter Trial to Evaluate the Effects of Withdrawal of Quinapril Hydrochloride on Exercise Tolerance in Patients With Mild to Moderate Congestive Heart Failure (906-276). Ann Arbor, Mich: Parke-Davis Pharmaceutical Research; April 1994. Unpublished report.
32. Uprichard A. An 18-Week Double Blind, Optional Titration, Multicenter Study to Compare the Efficacy and Safety of Orally Administered Quinapril Hydrochloride With Captopril and Placebo in Patients With Congestive Heart Failure (906-226). Ann Arbor, Mich: Parke-Davis Pharmaceutical Research; April 1994. Unpublished report.
33. Uprichard A. A 12-Week Double Blind, Placebo Controlled Study to Determine the Efficacy and Safety of Orally Administered Quinapril Hydrochloride in Patients With Congestive Heart Failure (906-63). Ann Arbor, Mich: Parke-Davis Pharmaceutical Research; April 1994. Unpublished report.
34. Swedberg K, Amtorp O, Gundersen T, Remes J, Nilsson B. Is maximal exercise testing a useful method to evaluate treatment of moderate heart failure? Circulation. 1991;57:226. Abstract.
35. Maass L. Double-Blind Comparative Trial With Ramipril and Placebo in Patients With Heart Failure (NYHA Class III-IV) Stabilized on Digitalis and Furosemides. Frankfurt, Germany: Hoechst Aktiengesellschaft; October 1991. Unpublished report.
36. Gordon M. Evaluation of the Efficacy and Safety of Ramipril (HOE 498) in Patients With Congestive Heart Failure in a Placebo-Controlled Trial. Somerville, NJ: Hoechst-Roussel Pharmaceuticals; October 1991. Unpublished report.
37. Maass L. Efficacy and Safety of Ramipril (HOE 498) in Patients With Congestive Heart Failure in a Double Blind Placebo Controlled Trial. Frankfurt, Germany: Hoechst Aktiengesellschaft; October 1991. Unpublished report.
38. Maass L. Evaluation of the Effect of Ramipril (HOE 498) on Exercise Duration, Invasive Cardiac Hemodynamics Profiles, and Safety in Patients With Congestive Heart Failure. Frankfurt, Germany: Hoechst Aktiengesellschaft; October 1991. Unpublished report.
39. Lemarie JC. Multicenter Double-Blind Placebo-Controlled Study of the Efficacy and Safety of Ramipril Administered Orally for 24 Weeks in the Treatment of Stable Chronic Congestive Cardiac Failure. Paris, France: Laboratories Hoechst; December 1992. Unpublished report.
40. Kramer BL, Massie BM, Topic N. Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study. Circulation. 1983;4: 807-816.
41. Captopril Multicenter Research Group. A placebo controlled trial of captopril in refractory chronic congestive heart failure. J Am Coll Cardiol. 1983; 2:755-763.
42. Chrysant SG, Gollub S, Dunn MI, Bal IS, Dreiling R, Konijeti JR. Hemodynamic and metabolic effects of enalapril in patients with heart failure. Clin Cardiol. 1985;8:585-590.
43. Franciosa JA, Wilen MM, Jordan RA. Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure. J Am Coll Cardiol. 1985;5:101-107.
44. Creager MA, Massie BM, Faxon DP, et al. Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure. J Am Coll Cardiol. 1985;6:163-170.
45. Sharpe DN, Murphy J, Caxon R, Hannan SF. Enalapril in patients with chronic heart failure: a placebo-controlled randomized, double-blind study. Circulation. 1984;70:271-278.
46. Jenning G, Kiat H, Nelson L, Kelly MJ, Kalff V, Johns J. Enalapril for severe congestive heart failure. Med J Aust. 1984;141:723-726.
47. McGrath BPO, Arnolda L, Matthews PG, Jackson B, Jennings G, Kiat H, Johnson C. Controlled trial of enalapril in congestive cardiac failure. Br Heart J. 1985;54:405-414.
48. McGrath BP, Arnolda LF. Enalapril reduces the catecholine response to exercise in patients with heart failure. Eur J Clin Pharmacol. 1986; 30:485-487.
49. Joy M, Hubner PJ, Thomas RD, Cummin P, Dews I, William H, Shahrabani R. Long-term use of enalapril in the treatment of patients with congestive heart failure. Int J Cardiol. 1987;16:137-144.
50. Remes J, Nikander P, Rehnberg S, et al. Enalapril in chronic heart failure: a double-blind placebo-controlled study. Ann Clin Res. 1986;18:124-128.
51. Webster MWJ, Fitzpatrick MA, Hamilton EJ, et al. Effects of enalapril on clinical status, biochemistry, exercise performance and hemodynamics in heart failure. Drug. 1985;30(suppl I):74-81.
52. Lewis GR. Comparison of lisinopril versus placebo for congestive heart failure. Am J Cardiol. 1989;63:12D-16D.
53. Lewis GR. Lisinopril versus placebo in older congestive heart failure. Am J Med. 1988;85(suppl 3B):48-54.
54. Chalmers JP, West MJ, Cyran J, et al. Placebo-controlled study of lisinopril in congestive heart failure: a multicentre study. J Cardiovasc Pharmacol. 1987;9(suppl 3):S85-S97.
55. Giles TD. Lisinopril in the treatment of congestive heart failure. J Hum Hypertens. 1989;3:83-87.
56. Lechat P, Garnham SP, Desche P, Bounhoure JP. Efficacy and acceptability of perindopril in mild to moderate chronic congestive heart failure. Am Heart J. 1993;126:798-806.